Stock screenerAll disclosures →
EDGAR →
CVKD
Conviction 0HealthcareScan · Mon, Jul 20, 2026CVKD$2.15-0.69%
ResistanceSupportVol 14Insider sellVol MA14 99.68K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price2.15
Change-0.69%
Gap+2.31%
Rel volume0.01×
Avg volume88.92K
Avg $ vol260.35K
SMA 202.88
SMA 503.93
SMA 2007.41
Price vs 50-45.40%
Price vs 200-71.04%
MA stackbearish
50/200 cross—
Supertrenddown · 3.25
RSI (14)27
MACD hist-0.04
MACD crossbear · 4d
Stoch %K / %D2 / 2
ADX (14)28
+DI / −DI13 / 25
RSI divergenceBullish
MACD divergenceBullish
ATR %+18.50%
ADR %13.95%
52w high14.20
52w low2.15
From 52w high-84.89%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width57.55%
%B0.06
Donchian pos1.97%
Donchian high3.89
Donchian low2.11
AVWAP (52w high)6.74
vs AVWAP high-68.19%
AVWAP (52w low)2.16
vs AVWAP low-0.46%
OBV trendDown
Chaikin MF (20)-0.41
Today vs 20d0.01×
Avg vol (14d)99.68K
Avg vol (20d)88.92K
Avg $ vol (20d)260.35K
Market cap6.15M
RS 3m (vs SPY)-61.40%
RS 6m (vs SPY)-81.95%
RS line new highNo
Trend template0/8
Technical rank2.4
1 week-11.36%
1 month-30.81%
3 months-58.91%
6 months-73.84%
1 year-81.93%
YTD-70.74%
P/E-0.46
P/B3.42
P/S—
P/FCF-0.49
EPS-6.64
Div yield—
ROE-736.59%
ROA-462.51%
Debt/Eq0.33
Current2.68
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-24.28%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value4.44M
Revenue—
Net income-2.5M
Gross profit—
Free cash flow-12.61M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out2.87M
Employees5
ListedFri, Jan 20, 2023
Free float1.78M
Float %76.1%
Short interest82.02K
Days to cover1.2d
Short volume38.0%
Squeeze score15 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank2.4 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.26
Support2.42
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CVKD
No recent disclosed trades by Congress in CVKD. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CVKD · 9 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-26 | Sell | 9.03K | $28K | 2026-06-26 | 2026-06-26 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-25 | Sell | 2.13K | $6K | 2026-06-25 | 2026-06-26 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-23 | Sell | 2.28K | $7K | 2026-06-23 | 2026-06-24 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-22 | Sell | 9.17K | $33K | 2026-06-22 | 2026-06-24 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-17 | Sell | 513 | $2K | 2026-06-17 | 2026-06-18 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-16 | Sell | 3.61K | $11K | 2026-06-16 | 2026-06-18 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-10 | Sell | 3.5K | $15K | 2026-06-10 | 2026-06-10 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-09 | Sell | 12.99K | $53K | 2026-06-09 | 2026-06-10 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-08 | Sell | 5.89K | $26K | 2026-06-08 | 2026-06-10 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-08 | Other | — | — | 2026-06-08 | 2026-06-10 |
SEC filings
EDGAR filings in CVKD · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.